By leveraging the expertise of SRx Health’s management team, their pre-existing relationships with pharma, and their robust infrastructure, Better Choice can complement its Halo portfolio of premium ...
The company’s California HMO contract – representing roughly 86% of its Medicare Advantage (MA) membership – has earned an overall 4- out of 5-star rating, marking its eighth consecutive year as a ...
Nelipak Corporation (“Nelipak”), a leading global manufacturer of packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced it has ...
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting ...
At PCF, Auron will present in vitro and in vivo data from AUTX-703, its oral, potent and selective degrader of KAT2A/B that is being developed for the treatment of AML and neuroendocrine carcinomas ...
Princeton, NJ, October 11, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that it has launched a generic paclitaxel formulation in the US, the first generic to ...
The poster presentation can be found on Alterity’s website here.
About Tourmaline Bio Tourmaline is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with ...
Realigning resources to focus on clinical advancement of Selected TIL therapy Streamlining operations with cash runway expected to extend into 2Q 2026 SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- ...
Cette équipe de l’Université de Nagoya vient d’identifier des protéines sanguines qui permettent de suivre la progression ...
À travers ce nouvel engagement, Curia participe également à la campagne Race to Zero (« objectif zéro ») soutenue par les Nations Unies, réunissant une coalition mondiale d’acteurs non étatiques ...
Paris, 11 octobre 2024. Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une participation de contrôle de 50% dans Opella, son activité de santé grand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback